CI

At a glance

ClinicalIndex Comparison Record
Phase 1Completed· 10 enrolled
Drug / intervention
Tolvaptandrug
Likely dose
Tolvaptan 7.5mgfrom record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT07166783
NCT07166783Phase 1Completed
CompareCT.gov

Pharmacokinetics, Pharmacological Effects and Safety of Single Dose of 7.5mg Tolvaptan Tablet in Healthy Male Subjects

Otsuka Beijing Research Institute·interventional·Posted Sep 10, 2025·Updated Sep 10, 2025

In Brief

A Phase 1 clinical trial evaluating Tolvaptan for Health Subjects. Completed, enrolled 10 participants.

Detailed Summary

Pharmacokinetics, pharmacological effects and safety of single dose of 7.5mg Tolvaptan tablet in healthy male subjects

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealth Subjects
Countries--
Collaborators--

Timeline

Phase 1CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedSep 10, 2025
Enrollment StartJun 16, 2011
Primary CompletionJul 4, 2011
TodayJul 2, 2026
Enrollment to primary: 18 daysPosted 10 months ago

Interventions

Tolvaptandrug

single dose oral administration of 7.5mg Tolvaptan